BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36384649)

  • 21. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.
    Ye LC; Liu TS; Ren L; Wei Y; Zhu DX; Zai SY; Ye QH; Yu Y; Xu B; Qin XY; Xu J
    J Clin Oncol; 2013 Jun; 31(16):1931-8. PubMed ID: 23569301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
    Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
    Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
    Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for
    Tang W; Ren L; Liu T; Ye Q; Wei Y; He G; Lin Q; Wang X; Wang M; Liang F; Cui Y; Xu J
    J Clin Oncol; 2020 Sep; 38(27):3175-3184. PubMed ID: 32749938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
    Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
    Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
    Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer-Predictive Factors and Prognosis.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Kaneko M; Murono K
    Clin Colorectal Cancer; 2018 Mar; 17(1):e91-e97. PubMed ID: 29113730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatectomy for liver metastases in non-colorectal, non-neuroendocrine cancer patients. The survival benefit in primary unresectable cases.
    Maeda Y; Shinohara T; Katayama T; Futakawa N; Hamada T
    Int J Surg; 2015 Oct; 22():136-42. PubMed ID: 26277530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
    Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
    Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases.
    Pamecha V; Nedjat-Shokouhi B; Gurusamy K; Glantzounis GK; Sharma D; Davidson BR
    Dig Surg; 2008; 25(5):387-93. PubMed ID: 19033722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.
    Olthof PB; Huiskens J; Wicherts DA; Huespe PE; Ardiles V; Robles-Campos R; Adam R; Linecker M; Clavien PA; Koopman M; Verhoef C; Punt CJ; van Gulik TM; de Santibanes E
    Surgery; 2017 Apr; 161(4):909-919. PubMed ID: 28038862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.
    Power DG; Kemeny NE
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):251-64. PubMed ID: 20970353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
    Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.
    Miyanari N; Mori T; Takahashi K; Yasuno M
    Dis Colon Rectum; 2002 Nov; 45(11):1503-9. PubMed ID: 12432299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.